Rhythm Pharmaceuticals Stock Price on December 9, 2024
| RYTM Stock | USD 56.12 0.64 1.15% |
Below is the normalized historical share price chart for Rhythm Pharmaceuticals extending back to October 05, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Rhythm Pharmaceuticals stands at 56.12, as last reported on the 21st of December, with the highest price reaching 58.16 and the lowest price hitting 55.47 during the day.
If you're considering investing in Rhythm Stock, it is important to understand the factors that can impact its price. Rhythm Pharmaceuticals appears to be very steady, given 3 months investment horizon. Rhythm Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0622, which implies the firm had a 0.0622% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Rhythm Pharmaceuticals, which you can use to evaluate the volatility of the company. Please evaluate Rhythm Pharmaceuticals' Coefficient Of Variation of 3453.47, risk adjusted performance of 0.0304, and Semi Deviation of 2.77 to confirm if our risk estimates are consistent with your expectations.
At this time, Rhythm Pharmaceuticals' Other Stockholder Equity is very stable compared to the past year. As of the 21st of December 2024, Stock Based Compensation is likely to grow to about 34.2 M, while Common Stock Total Equity is likely to drop about 36.4 K. . At this time, Rhythm Pharmaceuticals' Price Book Value Ratio is very stable compared to the past year. As of the 21st of December 2024, Price Earnings To Growth Ratio is likely to grow to 1.71, while Price Earnings Ratio is likely to drop (15.07). Rhythm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of October 2017 | 200 Day MA 46.8715 | 50 Day MA 55.9744 | Beta 2.093 |
Rhythm |
Sharpe Ratio = 0.0622
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RYTM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.15 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.2 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Rhythm Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rhythm Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 304.0248 | Enterprise Value Ebitda (12.65) | Price Sales 30.6494 | Shares Float 45.2 M | Wall Street Target Price 72.8182 |
Related Headline
Allogene Therapeutics Headline on 9th of December 2024
Disposition of 9136 shares by Messemer Deborah M. of Allogen... by gurufocus.com
Filed transaction by Allogene Therapeutics Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Rhythm Pharmaceuticals Valuation on December 9, 2024
It is possible to determine the worth of Rhythm Pharmaceuticals on a given historical date. On December 9, 2024 Rhythm was worth 59.04 at the beginning of the trading date compared to the closed value of 57.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Rhythm Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Rhythm Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rhythm Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Rhythm Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 58.51 | 59.35 | 58.32 | 58.89 | 346,699 | |
12/09/2024 | 59.04 | 59.29 | 56.43 | 57.41 | 299,790 |
| 57.20 | 58.46 | 56.85 | 57.74 | 522,157 |
| Backtest Rhythm Pharmaceuticals | | | Rhythm Pharmaceuticals History | | | Rhythm Pharmaceuticals Valuation | Previous | Next |
Rhythm Pharmaceuticals Trading Date Momentum on December 9, 2024
| On December 10 2024 Rhythm Pharmaceuticals was traded for 57.74 at the closing time. The top price for the day was 58.46 and the lowest listed price was 56.85 . The trading volume for the day was 522.2 K. The trading history from December 10, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 0.57% . The trading delta at closing time against the current closing price is 5.68% . |
Rhythm Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Rhythm Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Rhythm Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Rhythm financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Rhythm Pharmaceuticals Stock history
Rhythm Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rhythm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rhythm Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rhythm Pharmaceuticals stock prices may prove useful in developing a viable investing in Rhythm Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 57.7 M | 39.3 M | |
| Net Loss | -163 M | -154.9 M |
Rhythm Pharmaceuticals Quarterly Net Working Capital |
|
Rhythm Pharmaceuticals Stock Technical Analysis
Rhythm Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Rhythm Pharmaceuticals Period Price Range
Low | December 21, 2024
| High |
0.00 | 0.00 |
Rhythm Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Rhythm Pharmaceuticals December 21, 2024 Market Strength
Market strength indicators help investors to evaluate how Rhythm Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rhythm Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Rhythm Pharmaceuticals stock market strength indicators, traders can identify Rhythm Pharmaceuticals entry and exit signals to maximize returns
Rhythm Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Rhythm Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Rhythm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rhythm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0304 | |||
| Jensen Alpha | 0.0335 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.0204 | |||
| Treynor Ratio | 0.0377 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rhythm Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rhythm Pharmaceuticals. If investors know Rhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rhythm Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.32) | Revenue Per Share 1.863 | Quarterly Revenue Growth 0.478 | Return On Assets (0.46) | Return On Equity (1.48) |
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rhythm Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rhythm Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rhythm Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.